President’s Cancer Panel shared on LinkedIn:
“Tune in tomorrow at 9:00 am ET for the President’s Cancer Panel meeting, Opportunities to Reduce Obesity-Related Cancer Risk: GLP-1 Medications.
Subject matter experts will discuss biological mechanisms linking obesity to cancer and explore the possibility of harnessing GLP-1 medications for cancer prevention.
Register to attend this virtual meeting.”
You can also read: Muna Al-Khaifi: GLP-1 Receptor Agonists and the Future of Cancer Prevention and Survivorship
